A PHASE 1 STUDY OF SU011248 IN COMBINATION WITH FOLFIRI (IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN) IN PATIENTS WITH METASTATIC COLORECTAL CANCER

NIAID Data Ecosystem2026-03-06 收录

转移性结直肠癌I期临床试验

药物联合治疗安全性评估

数据链接：

https://www.omicsdi.org/dataset/ecrin-mdr-crc/2517000 数据链接链接失效反馈

官方服务：

资源简介：

Primary objectives: To assess the Maximum Tolerated Dose (MTD) and overall safety and tolerability of SU011248 in combination with FOLFIRI Primary endpoints: Objective Response Rate (ORR)

创建时间：

2005-08-15

A PHASE 1 STUDY OF SU011248 IN COMBINATION WITH FOLFIRI (IRINOTECAN, 5-FLUOROURACIL AND LEUCOVORIN) IN PATIENTS WITH METASTATIC COLORECTAL CANCER

资源简介：

相关数据集